These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 10770025)

  • 21. Improved urea clearance raises the BUN in continuous peritoneal dialysis.
    Baltzan MA; Shoker AA; Baltzan RB; Pylypchuk GB
    Clin Nephrol; 1996 Mar; 45(3):183-7. PubMed ID: 8706360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peritoneal urea and creatinine clearances in continuous peritoneal dialysis patients with different types of peritoneal solute transport.
    Tzamaloukas AH; Murata GH; Piraino B; Rao P; Bernardini J; Malhotra D; Oreopoulos DG
    Kidney Int; 1998 May; 53(5):1405-11. PubMed ID: 9573559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Online conductivity monitoring of dialysis adequacy versus Kt/V derived from urea reduction ratio: a prospective study from a Saudi Center.
    Al Saran K; Sabry A; Abdulghafour M; Yehia A
    Ren Fail; 2010 Jan; 32(1):36-40. PubMed ID: 20113264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitrogen balance studies and Kt/V urea in children undergoing chronic peritoneal dialysis.
    Cano FJ; Azocar MA; Delucchi MA; Rodriguez EE; Marin VS; Diaz ED; Mazuel N
    Adv Perit Dial; 2004; 20():245-50. PubMed ID: 15384835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An integrative description of dialysis adequacy indices for different treatment modalities and schedules of dialysis.
    Debowska M; Waniewski J; Lindholm B
    Artif Organs; 2007 Jan; 31(1):61-9. PubMed ID: 17209962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence that urea is a better surrogate marker of uremic toxicity than creatinine.
    Mehrotra R; Saran R; Nolph KD; Moore HL; Khanna R
    ASAIO J; 1997; 43(5):M858-61. PubMed ID: 9360168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Weight deficit in patients on continuous ambulatory peritoneal dialysis.
    Tzamaloukas AH; Murata GH; Servilla KS; Hoffman RM
    Am J Kidney Dis; 2002 May; 39(5):1068-77. PubMed ID: 11979352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of CAPD prescription.
    Acchiardo SR; Kraus AP; Kaufman PA; LaHatte G; Adkins D; Moore LW
    Adv Perit Dial; 1991; 7():47-50. PubMed ID: 1680455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Higher Kt/V is needed for adequate dialysis if the treatment time is reduced. Insights from a blood flow distribution model.
    Haraldsson B
    Nephrol Dial Transplant; 1995 Oct; 10(10):1845-51. PubMed ID: 8592592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urea kinetic modelling in two groups of patients on continuous ambulatory peritoneal dialysis.
    Barton EN; Morgan AG; Burden RP
    West Indian Med J; 1997 Jun; 46(2):57-9. PubMed ID: 9260536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dialysis adequacy indices for peritoneal dialysis and hemodialysis.
    Debowska M; Waniewski J; Lindholm B
    Adv Perit Dial; 2005; 21():94-7. PubMed ID: 16686294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Weekly KT/V urea and selected outcome criteria in 56 randomly selected CAPD patients.
    Mooraki A; Kliger AS; Gorban-Brennan NL; Juergensen P; Brown E; Finkelstein FO
    Adv Perit Dial; 1993; 9():92-6. PubMed ID: 8105972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical application of the Personal Dialysis Capacity (PDC) test: serial analysis of peritoneal function in CAPD patients.
    Imai H; Satoh K; Ohtani H; Hamai K; Haseyama T; Komatsuda A; Miura AB
    Kidney Int; 1998 Aug; 54(2):546-53. PubMed ID: 9690222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fractional solute removal and KT/V in different modalities of renal replacement therapy.
    Waniewski J; Lindholm B
    Blood Purif; 2004; 22(4):367-76. PubMed ID: 15297787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Assessment of nutrition in dialysis patients and chronic uremic patients].
    Liu H; Duan X; Li G
    Zhonghua Nei Ke Za Zhi; 1997 Nov; 36(11):727-30. PubMed ID: 10451942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The solute removal index--a unified basis for comparing disparate therapies.
    Keshaviah P
    Perit Dial Int; 1995; 15(2):101-4. PubMed ID: 7612726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An analysis of adequacy of dialysis in a selected population on CAPD for over 3 years: the influence of urea and creatinine kinetics.
    Selgas R; Bajo MA; Fernandez-Reyes MJ; Bosque E; Lopez-Revuelta K; Jimenez C; Borrego F; de Alvaro F
    Nephrol Dial Transplant; 1993; 8(11):1244-53. PubMed ID: 8302464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitrogen and urea metabolism during continuous ambulatory peritoneal dialysis.
    Blumenkrantz MJ; Kopple JD; Moran JK; Grodstein GP; Coburn JW
    Kidney Int; 1981 Jul; 20(1):78-82. PubMed ID: 7300117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Once-weekly hemodialysis helps continuous ambulatory peritoneal dialysis patients who have insufficient solute removal.
    Kanno Y; Suzuki H; Nakamoto H; Okada H; Sugahara S
    Adv Perit Dial; 2003; 19():143-7. PubMed ID: 14763051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.